TY - JOUR
T1 - Folate-mediated targeting
T2 - From diagnostics to drug and gene delivery
AU - Leamon, Christopher P.
AU - Low, Philip
PY - 2001/1/1
Y1 - 2001/1/1
N2 - The covalent attachment of the vitamin folic acid to almost any molecule yields a conjugate that can be endocytosed into folate receptor-bearing cells. Because folate receptors are significantly overexpressed in the majority of human cancers, this methodology is currently being investigated for the selective delivery of imaging and therapeutic agents to tumor tissue. Phase I and II clinical studies for the first folate-containing imaging agent were initiated in 1999, and clinical trials of folate-targeted therapeutic agents should soon follow. This review will summarize folate-mediated drug delivery and highlight those techniques undergoing active preclinical or clinical investigation.
AB - The covalent attachment of the vitamin folic acid to almost any molecule yields a conjugate that can be endocytosed into folate receptor-bearing cells. Because folate receptors are significantly overexpressed in the majority of human cancers, this methodology is currently being investigated for the selective delivery of imaging and therapeutic agents to tumor tissue. Phase I and II clinical studies for the first folate-containing imaging agent were initiated in 1999, and clinical trials of folate-targeted therapeutic agents should soon follow. This review will summarize folate-mediated drug delivery and highlight those techniques undergoing active preclinical or clinical investigation.
UR - http://www.scopus.com/inward/record.url?scp=0035135353&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035135353&partnerID=8YFLogxK
U2 - 10.1016/S1359-6446(00)01594-4
DO - 10.1016/S1359-6446(00)01594-4
M3 - Review article
AN - SCOPUS:0035135353
SN - 1359-6446
VL - 6
SP - 44
EP - 51
JO - Drug Discovery Today
JF - Drug Discovery Today
IS - 1
ER -